Breaking News Instant updates and real-time market news.

T

AT&T

$39.06

-0.36 (-0.91%)

11:42
10/05/16
10/05
11:42
10/05/16
11:42

AT&T announces IoT data plans

AT&T is introducing data plans for developers and businesses to wirelessly connect their Internet of Things projects. With these data plans, developers can purchase a bucket of prepaid data to power up to a thousand devices on the AT&T network. Available later this month, the IoT data plans give developers a flexible and fast way to deploy their devices and an entry point into deploying IoT solutions. As a customer's connectivity needs grow, AT&T will work directly with the customer on different options. AT&T has three IoT data plans for customers choose from: Option 1: 1 GB for $25.00, includes 500 SMS; Option 2: 3 GB for $60.00, includes 1000 SMS; Option 3: 5 GB for $100.00, includes 1500 SMS.

  • 24

    Oct

T AT&T
$39.06

-0.36 (-0.91%)

09/26/16
HSBC
09/26/16
UPGRADE
Target $38
HSBC
Hold
AT&T upgraded to Hold from Reduce at HSBC
HSBC analyst Sunil Rajgopal upgraded AT&T to Hold with a $38 price target.
09/26/16
09/26/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AT&T (T) upgraded to Hold from Reduce at HSBC. 2. Potash (POT) upgraded to Positive from Neutral at Susquehanna with analyst Don Carson citing expected benefits from the company's proposed merger with Agrium (AGU), which he sees as having relatively low antitrust risk compared to the other mega-mergers being pursued in the Ag space. 3. Oshkosh (OSK) upgraded to Overweight from Neutral at JPMorgan and to Neutral from Underperform at Credit Suisse. 4. Marriott (MAR) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Thomas Allen citing strong unit growth. 5. NetApp (NTAP) upgraded to Buy from Hold at Cross Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/28/16
UBSW
09/28/16
DOWNGRADE
Target $43
UBSW
Neutral
AT&T downgraded to Neutral from Buy at UBS
UBS analyst John Hodulik downgraded AT&T to Neutral citing expectations for lower earnings growth. The analyst reduced his earnings estimates by 3% to reflect the "increased competitive intensity" in wireless and incremental costs associated with AT&T's DTV Now roll-out. Hodulik cut his price target for AT&T shares to $43 from $46.
09/28/16
09/28/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Underperform from Neutral at Wedbush with analyst James Dix citing concerns that the "Four Horsemen of the Search Apocalypse" -- self-identified consumers, consumer control of IP-delivered ads, payments innovation, and attention markets -- might arrive. 2. AT&T (T) downgraded to Neutral from Buy at UBS with analyst John Hodulik citing expectations for lower earnings growth. 3. Macy's (M) downgraded to Neutral from Outperform at Credit Suisse with analyst Michael Exstein saying the retailer, after outlining in August its operations and merchandising strategies, is now in an execution phase. 4. Twitter (TWTR) downgraded to Underperform from Neutral at Mizuho and to Sell from Hold at Loop Capital. 5. Galectin Therapeutics (GALT) downgraded to Sell from Buy at Roth Capital with analyst Sa'ar Yaniv citing the company's announcement that NASH-FX, GR-MD-02's Phase 2a study in NASH fibrosis, failed both primary and secondary endpoints. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

08:15
06/28/17
06/28
08:15
06/28/17
08:15
General news
Energy Action: NYMEX »

Energy Action: NYMEX…

08:15
06/28/17
06/28
08:15
06/28/17
08:15
General news
International Trade in Goods Balance to be reported at 08:30 »

May International Trade…

LNCE

Snyder's-Lance

$34.88

-1.27 (-3.51%)

08:14
06/28/17
06/28
08:14
06/28/17
08:14
Hot Stocks
Snyder's-Lance appoints Brian Driscoll as CEO »

Snyder's-Lance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MON

Monsanto

$117.25

-0.55 (-0.47%)

08:14
06/28/17
06/28
08:14
06/28/17
08:14
Earnings
Monsanto sees FY17 ongoing EPS $4.50-$4.90, consenus $4.89 »

The company confirms EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MON

Monsanto

$117.25

-0.55 (-0.47%)

, BAYRY

Bayer

$137.59

0.89 (0.65%)

08:14
06/28/17
06/28
08:14
06/28/17
08:14
Earnings
Monsanto reports Q3 ongoing EPS $1.93, consensus $1.76 »

Reports Q3 revenue…

MON

Monsanto

$117.25

-0.55 (-0.47%)

BAYRY

Bayer

$137.59

0.89 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

TYG

Tortoise Energy

$29.13

-0.14 (-0.48%)

08:13
06/28/17
06/28
08:13
06/28/17
08:13
Upgrade
Tortoise Energy rating change  »

Tortoise Energy upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBT

Global Blood Therapeutics

$27.50

-0.4 (-1.43%)

08:12
06/28/17
06/28
08:12
06/28/17
08:12
Hot Stocks
Global Blood Therapeutics receives EMA PRIME designation for GBT440 »

Global Blood Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNF

UniFirst

$139.05

-1.25 (-0.89%)

08:12
06/28/17
06/28
08:12
06/28/17
08:12
Earnings
UniFirst sees FY17 EPS $4.85-$5.00, consensus $5.01 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

UNF

UniFirst

$139.05

-1.25 (-0.89%)

08:11
06/28/17
06/28
08:11
06/28/17
08:11
Earnings
UniFirst reports Q3 adj. EPS $1.36, consensus $1.34 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MNRO

Monro Muffler

$45.15

-0.8 (-1.74%)

08:10
06/28/17
06/28
08:10
06/28/17
08:10
Hot Stocks
Monro Muffler appoints Ponton to succeed Van Heel as CEO »

Monro Muffler Brake…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUVA

NuVasive

$75.54

-1.15 (-1.50%)

08:08
06/28/17
06/28
08:08
06/28/17
08:08
Recommendations
NuVasive analyst commentary  »

NuVasive price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 15

    Aug

CA

CA Technologies

$34.62

-0.19 (-0.55%)

08:08
06/28/17
06/28
08:08
06/28/17
08:08
Recommendations
CA Technologies analyst commentary  »

Potential CA Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPO

XPO Logistics

$60.84

-0.32 (-0.52%)

08:06
06/28/17
06/28
08:06
06/28/17
08:06
Initiation
XPO Logistics initiated  »

XPO Logistics initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jul

CBI

CB&I

$20.03

5.63 (39.10%)

08:04
06/28/17
06/28
08:04
06/28/17
08:04
Hot Stocks
CB&I awarded contract by Shurtan Gas Chemical Complex »

CB&I announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMNX

Luminex

$20.92

-0.3 (-1.41%)

08:04
06/28/17
06/28
08:04
06/28/17
08:04
Hot Stocks
Luminex receives CE-IVD mark for ARIES Norovirus Assay »

Luminex announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

NVIV

InVivo Therapeutics

$2.75

0.2 (7.84%)

08:04
06/28/17
06/28
08:04
06/28/17
08:04
Hot Stocks
InVivo Therapeutics reports two patients in study improve in INSPIRE assessments »

InVivo Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

MSA

MSA Safety

$79.73

0.44 (0.55%)

08:03
06/28/17
06/28
08:03
06/28/17
08:03
Hot Stocks
MSA Safety to acquire Globe Holding Company for $215M in cash »

MSA Safety announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCA

HCA Holdings

$86.01

-0.61 (-0.70%)

07:59
06/28/17
06/28
07:59
06/28/17
07:59
Initiation
HCA Holdings initiated  »

HCA Holdings initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STT

State Street

$87.90

0.08 (0.09%)

07:59
06/28/17
06/28
07:59
06/28/17
07:59
Upgrade
State Street rating change  »

State Street upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

OLN

Olin Corp.

$29.31

0.29 (1.00%)

07:58
06/28/17
06/28
07:58
06/28/17
07:58
Recommendations
Olin Corp. analyst commentary  »

Cowen calls Olin Corp. a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSKE

Daseke

$10.40

0.09 (0.87%)

07:57
06/28/17
06/28
07:57
06/28/17
07:57
Recommendations
Daseke analyst commentary  »

Daseke revenue synergies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRU

TransUnion

$43.52

-0.78 (-1.76%)

07:57
06/28/17
06/28
07:57
06/28/17
07:57
Recommendations
TransUnion analyst commentary  »

TransUnion guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

COST

Costco

$159.26

-0.94 (-0.59%)

, AMZN

Amazon.com

$976.78

-17.2 (-1.73%)

07:56
06/28/17
06/28
07:56
06/28/17
07:56
Recommendations
Costco, Amazon.com analyst commentary  »

Costco weakness a buying…

COST

Costco

$159.26

-0.94 (-0.59%)

AMZN

Amazon.com

$976.78

-17.2 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 23

    Aug

PYPL

PayPal

$52.73

-1.01 (-1.88%)

07:55
06/28/17
06/28
07:55
06/28/17
07:55
Recommendations
PayPal analyst commentary  »

PayPal shares could…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

07:55
06/28/17
06/28
07:55
06/28/17
07:55
General news
N.Y. FX Outlook »

N.Y. FX Outlook: The…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.